The biggest mouth in pharmaceuticals is keeping quiet — for once.
“Pharma bro” Martin Shkreli on Monday said he will not testify in his own defense at his securities fraud trial in Brooklyn, New York, federal court.
Shkreli’s decision was not surprising, because of the risk he ran from facing a blistering cross-examination by prosecutors, who have a huge trove of questionable prior statements by Shkreli to use against him.
While Shkreli has teed off on prosecutors to reporters earlier at his trial, and continues to spout off on Facebook, he apparently has less nerve when it comes to going on the record for jurors who will decide his fate.
